{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:25:51Z","timestamp":1772223951221,"version":"3.50.1"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.12788\/cutis.0519","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T12:16:41Z","timestamp":1654258601000},"source":"Crossref","is-referenced-by-count":7,"title":["Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing"],"prefix":"10.12788","volume":"21","author":[{"given":"Hadley","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","published-online":{"date-parts":[[2022,5,1]]},"container-title":["Current Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/CT109005265.PDF","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T12:16:44Z","timestamp":1654258604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/dermatology\/article\/254687\/contact-dermatitis\/dupilumab-allergic-contact-dermatitis-overview-its-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.0519","relation":{},"subject":[],"published":{"date-parts":[[2022,5,1]]}}}